Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
1,051,101
-
Shares change
-
-76,969
-
Total reported value, excl. options
-
$75,081,504
-
Value change
-
-$5,092,016
-
Number of buys
-
26
-
Number of sells
-
-34
-
Price
-
$71.39
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2020
92 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q4 2020.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,051,101 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (126,902 shares), Advocacy Wealth Management Services, LLC (95,992 shares), Brinker Capital Investments, LLC (94,700 shares), BANK OF AMERICA CORP /DE/ (79,927 shares), LPL Financial LLC (79,434 shares), GOLDMAN SACHS GROUP INC (50,133 shares), UBS Group AG (43,593 shares), ENVESTNET ASSET MANAGEMENT INC (41,478 shares), Federation des caisses Desjardins du Quebec (34,340 shares), and MORGAN STANLEY (32,255 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.